The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Connemara Mining, Circle Oil, Kenetics...

Mon, 21st Jun 2010 11:34

Irish zinc explorer Connemara Mining has intersected additional high grade zinc-lead mineralisation 400m to the southwest of the Stonepark North discovery in Limerick."The Stonepark discovery in Limerick is getting bigger and better," said chairman John Teeling. Circle Oil is "even more convinced" that it can deliver on its promise of accelerated growth and has looked at 60 potential projects in the greater Middle-East/North Africa area. Losses grew to $13.5m in 2009 from $10.7m the year before due to a non-cash charge linked to convertible loans, but first revenues of $15.1m from its operations in Egypt and Morocco led to a maiden gross profit of $7.4m. Shares in Kenetics jumped 40% today after the antenna supplier announced that it has raised £300,000, before expenses, by way of a placing of 7.5m new shares. The shares have been placed with Ken Wong, Chairman and Chief Executive and Yeong Hin Yuen, COO of the Company. Indian based security and facilities management company Mortice said the Indian economy is "beginning to display signs of recovery from the recessionary slumber." So far this year the company has won 76 new contracts that collectively are worth £3.05m per annum.Huge write-offs for its China-based licensee Diamond Wood plunged Accoya wood specialist Accsys deep in the red last year. Losses to end March came in at €52.2m against a profit of €1.8m, after a €35.5m write-off. Revenues fell to €16.7m after licence income slumped 71% to €6.7m. Accoya wood sales increased by one third to €9.1m. Aker BioSciences's adjusted losses rose to $4.6m from $1.2m in 2009 as sales fell to $1.8m from $6.1m. "We believe that the scale of opportunity for our PIFA Heparin/PF4 Rapid Assay, BreathScan PRO, Breath Ketone 'Check' and Breath PulmoHealth 'Check' will be the transformational, long-term drivers of growth and value," Thomas A Nicolette, President and CEO, commented. Ovoca Gold has announced its maiden gold resource estimate for its Olcha gold project, located on the Rassoshinskaya licence. This maiden resource of 344,000 ounces has been generated from historic drilling and trenching data, which includes 16,455 meters of diamond drilling (144 holes ranging in depth from 14.3 metres to 336.8 metres, average 124m) and 12.3 kilometres of trenching. Not all of the historic data was used in generating the resource model mainly due to the lack of data points between various results. The 2010 drill program at Olcha is designed to in-fill these gaps in data points to potentially expand the resource, the company said.Bidtimes, which invests in mining exploration projects in Australia, made a pre-tax loss of £101,358 in the 10 months to 31 December, down from £153,696 over the prior 12 months.
More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.